Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

J 2021

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

NOGUEIRA, R. G.; M. M. QURESHI; M. ABDALKADER; S. O. MARTINS; H. YAMAGAMI et. al.

Základní údaje

Originální název

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

Autoři

NOGUEIRA, R. G.; M. M. QURESHI; M. ABDALKADER; S. O. MARTINS; H. YAMAGAMI; Z. M. QIU; O. Y. MANSOUR; A. SATHYA; A. CZLONKOWSKA; G. TSIVGOULIS; D. A. DE SOUSA; J. DEMEESTERE; Robert MIKULÍK; P. VANACKER; J. E. SIEGLER; J. KORV; J. BILLER; C. W. LIANG; N. S. SANGHA; A. M. ZHA; A. L. CZAP; C. A. HOLMSTEDT; T. N. TURAN; G. NTAIOS; K. MALHOTRA; A. TAYAL; A. LOOCHTAN; A. RANTA; E. A. MISTRY; A. W. ALEXANDROV; D. Y. HUANG; S. YAGHI; E. RAZ; S. A. SHETH; M. H. MOHAMMADEN; M. FRANKEL; E. G. B. LAMOU; H. M. AREF; A. ELBASSIOUNY; F. HASSAN; T. MENECIE; W. MUSTAFA; H. M. SHOKRI; T. ROUSHDY; F. S. SARFO; T. O. ALABI; B. ARABAMBI; E. O. NWAZOR; T. A. SUNMONU; K. WAHAB; J. YARIA; H. H. MOHAMMED; P. B. ADEBAYO; A. D. RIAHI a Sassi S. BEN

Vydání

Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2021, 0028-3878

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 12.258

Kód RIV

RIV/00216224:14110/21:00122752

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1212/WNL.0000000000011885

UT WoS

000702399700021

EID Scopus

2-s2.0-85106084873

Klíčová slova anglicky

COVID-19; Stroke Care; IV Thrombolysis

Štítky

14110127, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 8. 2. 2022 10:30, Mgr. Tereza Miškechová

Anotace

V originále

Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.

Návaznosti

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Citovat

@article{1801301,
   author = {Nogueira, R. G. and Qureshi, M. M. and Abdalkader, M. and Martins, S. O. and Yamagami, H. and Qiu, Z. M. and Mansour, O. Y. and Sathya, A. and Czlonkowska, A. and Tsivgoulis, G. and de Sousa, D. A. and Demeestere, J. and Mikulík, Robert and Vanacker, P. and Siegler, J. E. and Korv, J. and Biller, J. and Liang, C. W. and Sangha, N. S. and Zha, A. M. and Czap, A. L. and Holmstedt, C. A. and Turan, T. N. and Ntaios, G. and Malhotra, K. and Tayal, A. and Loochtan, A. and Ranta, A. and Mistry, E. A. and Alexandrov, A. W. and Huang, D. Y. and Yaghi, S. and Raz, E. and Sheth, S. A. and Mohammaden, M. H. and Frankel, M. and Lamou, E. G. B. and Aref, H. M. and Elbassiouny, A. and Hassan, F. and Menecie, T. and Mustafa, W. and Shokri, H. M. and Roushdy, T. and Sarfo, F. S. and Alabi, T. O. and Arabambi, B. and Nwazor, E. O. and Sunmonu, T. A. and Wahab, K. and Yaria, J. and Mohammed, H. H. and Adebayo, P. B. and Riahi, A. D. and Ben, Sassi S.},
   article_location = {Philadelphia},
   article_number = {23},
   doi = {https://doi.org/10.1212/WNL.0000000000011885},
   keywords = {COVID-19; Stroke Care; IV Thrombolysis},
   language = {eng},
   issn = {0028-3878},
   journal = {Neurology},
   title = {Global Impact of COVID-19 on Stroke Care and IV Thrombolysis},
   url = {https://n.neurology.org/content/96/23/e2824},
   volume = {96},
   year = {2021}
}

TY  - JOUR
ID  - 1801301
AU  - Nogueira, R. G. - Qureshi, M. M. - Abdalkader, M. - Martins, S. O. - Yamagami, H. - Qiu, Z. M. - Mansour, O. Y. - Sathya, A. - Czlonkowska, A. - Tsivgoulis, G. - de Sousa, D. A. - Demeestere, J. - Mikulík, Robert - Vanacker, P. - Siegler, J. E. - Korv, J. - Biller, J. - Liang, C. W. - Sangha, N. S. - Zha, A. M. - Czap, A. L. - Holmstedt, C. A. - Turan, T. N. - Ntaios, G. - Malhotra, K. - Tayal, A. - Loochtan, A. - Ranta, A. - Mistry, E. A. - Alexandrov, A. W. - Huang, D. Y. - Yaghi, S. - Raz, E. - Sheth, S. A. - Mohammaden, M. H. - Frankel, M. - Lamou, E. G. B. - Aref, H. M. - Elbassiouny, A. - Hassan, F. - Menecie, T. - Mustafa, W. - Shokri, H. M. - Roushdy, T. - Sarfo, F. S. - Alabi, T. O. - Arabambi, B. - Nwazor, E. O. - Sunmonu, T. A. - Wahab, K. - Yaria, J. - Mohammed, H. H. - Adebayo, P. B. - Riahi, A. D. - Ben, Sassi S.
PY  - 2021
TI  - Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
JF  - Neurology
VL  - 96
IS  - 23
SP  - "E2824"-"E2838"
EP  - "E2824"-"E2838"
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 00283878
KW  - COVID-19
KW  - Stroke Care
KW  - IV Thrombolysis
UR  - https://n.neurology.org/content/96/23/e2824
N2  - Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.
ER  -

Přehled o publikaci